Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Zadeh is Professor of Medicine at the Johns Hopkins University School of Medicine and Director of Cardiac Computed Tomography in the Division of Cardiology at the Johns Hopkins Hospital in Baltimore, MD. After attending medical school in Germany and completing internships in medicine and surgery in Germany and Britain, he spent several years in cardiovascular research at the University of California at San Diego to study coronary artery disease using intravascular ultrasound. He then completed his postgraduate training in Philadelphia and Dallas to join the cardiology faculty at Johns Hopkins Hospital after a CT imaging fellowship in 2005. Dr. Zadeh directs the CT coronary angiography core laboratory for the CorE-320 multicenter trial and is member of its steering committee. He is also co-director of the SCCT Board Review Course and editor of the SCCT Board Review Preparation Book. Dr. Zadeh's particular clinical and investigational focus is the pursuit of strategies to better identify patients at risk for future cardiac events using cardiac imaging. He reviews manuscripts for numerous scientific journals, including JACC, JACCimaging, JCCT, AJR, Heart, AJC, and is an author of articles in Circulation, New England Journal of Medicine, JACC, AHJ, and others. Dr. Arbab is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Heart Attack, Apoplexy, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Seamus Whelton MD, MPH, is an Associate Professor of Cardiology and member of the Ciccarone Center for the Prevention of Cardiovascular Disease. His primary clinical and research expertise includes the pathogenesis, risk prediction, prevention, and treatment of atherosclerotic cardiovascular disease with an emphasis on the identification of coronary artery calcium via cardiac CT scanning. He is Director of the Advanced Subclinical Atherosclerosis Clinic, which focuses on the treatment of patients with incidentally discovered coronary artery calcium detected by CT imaging. He is also an expert on the pathogenesis, epidemiology, and risk factors for aortic valve calcification. He has led pioneering research to describe the use aortic valve calcification to predict the risk of aortic stenosis. Dr. Whelton has published more than 130 peer reviewed manuscripts, multiple book chapters, and has been an invited lecturer at both national and international conferences. He is an Associate Editor at the Journal of Cardiovascular Computed Tomography and the American Journal of Preventive Cardiology. He is a member of the American College of Cardiology Prevention of Cardiovascular Disease Leadership Council. He has been the Principal Investigator on grants from the National Institutes of Health and American Heart Association. Dr. Whelton received his undergraduate degree at Princeton University. He then completed a Masters of Public Health in Epidemiology at the Tulane University School of Public Health and Tropical Medicine followed by his Doctor of Medicine degree from the Tulane University School of Medicine. He subsequently completed a post-doctoral fellowship at the Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Bloomberg School of Public Health and then completed a fellowship in Cardiology at the Johns Hopkins School of Medicine before joining the Cardiology Faculty at Johns Hopkins in 2017. Videos Dr. Seamus Whelton. Dr. Whelton is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Apoplexy, Coronary Heart Disease, Pacemaker Implantation, and Heart Bypass Surgery.

Sriram Padmanabhan is a Nuclear Medicine provider in Baltimore, Maryland. Dr. Padmanabhan is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Atrial Fibrillation, Atherosclerosis, and Angina.

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Dr. Brian Gustav Kral is Assistant Professor in the Division of Cardiology and General Internal Medicine as well as Assistant Professor of Radiology and Radiological Sciences at the Johns Hopkins School of Medicine. He is currently engaged in research on genetic and biological mechanisms of coronary atherosclerosis with an emphasis on plaque morphology and composition as well as coronary blood flow at different stages of disease progression. Dr. Kral received his undergraduate degree in economics and pre-medicine from The Johns Hopkins University. He received a master’s in public health from The Johns Hopkins School of Public Health. He also earned a medical degree from The Johns Hopkins School of Medicine. Dr. Kral completed his residency at the Mayo Graduate School of Medicine. He rejoined the Johns Hopkins community as a fellow in 2005 where he remained on Faculty after completion of his training. Besides his teaching and clinical engagements, Dr. Kral is currently the Program Director of Nuclear Cardiology at the Johns Hopkins School of Medicine. Dr. Kral is also Director of Clinical Studies for The Johns Hopkins GeneSTAR Research Program. The program aims to identify genetic and biological determinants of subclinical and clinical atherosclerotic disease and thrombosis in individuals with a strong family history of early-onset coronary artery disease. He has been recognized with the Stanley L. Blumenthal Cardiology Research Award for outstanding clinical research in cardiovascular disease from The Johns Hopkins Medical Institutions. Dr. Kral is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Apoplexy, Coronary Heart Disease, Heart Attack, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR).

Steven Hearne is a Cardiologist in Salisbury,, Maryland. Dr. Hearne is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Atrial Fibrillation, Angina, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Aloke Finn is a Cardiologist in Rockville,, Maryland. Dr. Finn is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Pulmonary Hypertension, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Mark Treuth is a Cardiologist in Salisbury, Maryland. Dr. Treuth is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Atrial Fibrillation, and Pacemaker Implantation.

Joseph Cinderella is a Cardiologist in Salisbury, Maryland. Dr. Cinderella is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Aortic Valve Stenosis, Angina, Coronary Heart Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Christian Bounds is a Cardiologist in Salisbury,, Maryland. Dr. Bounds is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atrial Fibrillation, Coronary Heart Disease, Angina, Pacemaker Implantation, and Heart Bypass Surgery.

Evan Selsky is a Cardiologist in Westminster, Maryland. Dr. Selsky is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Inappropriate Sinus Tachycardia (IST), Atherosclerosis, and Familial Ventricular Tachycardia.

Michael Drossner is a Cardiologist in Bel Air,, Maryland. Dr. Drossner is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Angina, Heart Attack, Dilated Cardiomyopathy (DCM), and Angioplasty.

Vivek Dhruva is a Cardiologist in Bel Air,, Maryland. Dr. Dhruva is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Cardiomyopathy, Atherosclerosis, and Angina.

Ramesh Agarwal is a Cardiologist in Salisbury, Maryland. Dr. Agarwal is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Stable Angina, and Pacemaker Implantation.

Robert Zawodny is a Cardiologist in Nottingham, Maryland. Dr. Zawodny is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Cardiomyopathy, and Angina.